Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Esophagus ; 17(4): 502-507, 2020 10.
Article En | MEDLINE | ID: mdl-32356213

BACKGROUND: Distal contractile integral (DCI) is influenced by factors other than esophageal smooth muscle contractility, such as intrabolus pressure and vascular and respiratory movements' artifacts. We aimed to determine the size of the contribution of pressures generated by vascular compression on the esophagus to the DCI measured in HRM recordings in symptomatic patients. METHODS: HRM manometry recordings obtained from 383 subjects referred to the GI motility laboratory at a tertiary center (2012-2016) were evaluated by visual inspection for evidence of strong vascular compression (SVC) of the esophagus. Clinical, demographic, manometric, and serologic data for Chagas disease were obtained. Subjects were classified, respectively, as asymptomatics (ASYM) or symptomatics (SYMP). DCI and SVC-DCI were measured, and the SVC-DCI/DCI ratio was expressed as a percentage and the difference between DCI and SVC-DCI (neat-DCI) was calculated. DCI, SVC-DCI, SVC-DCI/DCI % and neat-DCI from SYMP and ASYM were compared. RESULTS: SVC was conspicuous in 42 of 383 subjects (11%). In 33 subjects, SVC was detected only in supine position. SVC was localized in middle esophagus in 21 subjects (50%), in distal esophagus in 12 subjects (29%) and in both regions in 9 subjects (21%). In 9 subjects, SVC vanished from the swallowing window analysis (21%). CONCLUSIONS: SVC is a common finding in esophageal HRM study, particularly in the supine position. Occasionally, its contribution to DCI value is sufficiently great to masquerade esophageal hypocontractility. Different manometric protocols may be required in patients with SVC.


Chagas Disease/physiopathology , Esophageal Motility Disorders/physiopathology , Esophagus/blood supply , Manometry/methods , Muscle Contraction/physiology , Adult , Artifacts , Case-Control Studies , Chagas Disease/blood , Chagas Disease/diagnosis , Chagas Disease/epidemiology , Deglutition/physiology , Esophageal Motility Disorders/diagnosis , Esophagus/physiology , Female , Humans , Male , Middle Aged , Muscle, Smooth/physiology , Peristalsis/physiology , Pressure/adverse effects , Prevalence
2.
Int J Infect Dis ; 39: 110-5, 2015 Oct.
Article En | MEDLINE | ID: mdl-26376222

BACKGROUND: Kaposi's sarcoma (KS) is the most common neoplasm among HIV-infected individuals. The frequency of involvement of KS in the gastrointestinal (GI) tract and the associated epidemiological, immune, endoscopic, and histopathological features in HIV-infected patients, were evaluated in this study. METHODS: A review of the medical and endoscopy reports of 1428 HIV-infected patients, who had undergone upper GI endoscopy at the Endoscopy Service, Clinical Hospital, Faculty of Medicine of Ribeirão Preto between January 1999 and June 2009, was performed. Clinical, epidemiological, immunological, endoscopic, and histological data were collected. RESULTS: Twenty-seven (1.9%) patients were diagnosed with GI KS. Patients were predominantly male (81.5%). Sexual activity was the main route of HIV transmission (81.5%). Cutaneous involvement was noted in 21 patients (78%). Fifteen patients (55%) received highly active antiretroviral therapy for a mean duration of 12.6 weeks (range 2-52 weeks) before endoscopy. GI lesions were mainly found in the stomach (55%). Analysis of the immunohistochemical methods HHV8 LNA-1, CD31, and CD34 for the diagnosis of gastric KS indicated high agreement (kappa=0.63, 95% confidence interval 0.32-0.94). There was no relationship between CD4 levels (p=0.34) or HIV viral load (p=0.99) and HHV8 LNA-1 positivity in gastric KS. CONCLUSIONS: GI KS is an infrequent finding in patients with HIV infection. Among those with GI KS, 80% had concomitant skin lesions. Immunohistochemical methods for CD31, CD34, and LNA-1 were important tools in the diagnostic assessment of lesions suggestive of KS in the GI tract. Further studies are required to confirm these data, and the need for routine endoscopic investigation of the GI tract in HIV-infected patients with cutaneous KS should be assessed.


Gastrointestinal Neoplasms/diagnosis , Gastrointestinal Neoplasms/epidemiology , HIV Infections/complications , Sarcoma, Kaposi/diagnosis , Sarcoma, Kaposi/epidemiology , Adult , Antiretroviral Therapy, Highly Active , Brazil/epidemiology , Endoscopy, Digestive System , Female , Gastrointestinal Neoplasms/complications , Gastrointestinal Neoplasms/pathology , Humans , Male , Middle Aged , Sarcoma, Kaposi/complications , Sarcoma, Kaposi/pathology , Upper Gastrointestinal Tract , Young Adult
3.
Acta Histochem ; 112(6): 583-91, 2010 Nov.
Article En | MEDLINE | ID: mdl-19748654

Pregnant rats were exposed to ethanol (EtOH) and/or methyl mercury (MeHg) during fetal brain development. Nitrergic activity was quantified by densitometric measurement of formazan deposits in the hippocampus, cerebellum and striatum of two-month-old offspring following histochemical assay for NADPH-diaphorase (NADPH-d) activity. Compared to control subjects, an increase in nitrergic activity was found in the molecular layer of dentate gyrus and in the lacunosum molecular and stratum radiatum of CA1 (cornus amoni 1) in the EtOH+MeHg group, whereas a single administration of EtOH increased the activity in all striatal segments. The cerebellum seems to be less sensitive at this time-point to intoxication, and presented an increase only at the molecular layer of EtOH-exposed animals when compared to the MeHg and EtOH+MeHg groups (ANOVA, one-way followed by Tukey's test, p<0.05 or p<0.01). Taken together, results suggest that developmental exposure to EtOH and MeHg, singularly or in combination, alters nitrergic activity in adult rat in different ways depending on the region and layer of the central nervous system (CNS), and that these alterations might be related to different local metabolic properties.


Brain/drug effects , Ethanol/administration & dosage , Ethanol/toxicity , Methylmercury Compounds/administration & dosage , Methylmercury Compounds/toxicity , NADPH Dehydrogenase/metabolism , Nitric Oxide/metabolism , Prenatal Exposure Delayed Effects , Animals , Brain/metabolism , Female , Immunohistochemistry , Male , Pregnancy , Rats , Rats, Wistar
...